Lung Cancer;ESMO 2023;non-squamous tumors;Cancer Research

Antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer, delaying disease progression

[ad_1] BYLINE: Denise Heady Newswise — Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to…